MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Idiopathic pulmonary fibrosis

Drug Safety Update

July 2020: Systemically administered VEGF pathway inhibitors: risk of aneurysm and artery dissection

NICE guidance (see drug-specific links below)

CG163: Idiopathic pulmonary fibrosis in adults: diagnosis and management, June 2013 (last updated May 2017)

TA379: Nintedanib for treating idiopathic pulmonary fibrosis, January 2016

TA504: Pirfenidone for treating idiopathic pulmonary fibrosis, February 2018

These drugs are available from specialist centres only and should be initiated and supervised by an appropriate specialist

Pack Price
252 capsule (4 x 63 capsules) £2,007.70
270 capsule £2,151.10
63 capsule (1 x 21 caps + 1 x 42 caps) £501.92
Pack Price
252 tablet (4 x 63 tablets) £2,007.70
63 tablet (1 x 21 tabs + 2 x 21 tabs) £501.92
Pack Price
84 tablet (4 x 21 tablets) £2,007.70
Pack Price
60 capsule (6 x 10 capsules) £2,151.10
Pack Price
60 capsule (6 x 10 capsules) £2,151.10